Patents by Inventor Matthew Peter John

Matthew Peter John has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for the preparation of a biphenyl-2-yl carbamic acid ester
    Patent number: 8519138
    Abstract: A novel process for the preparation of the compound of formula (II): which process comprises reacting a compound of formula (VI): with a compound of formula (IV): in a suitable solvent.
    Type: Grant
    Filed: April 14, 2010
    Date of Patent: August 27, 2013
    Assignee: Glaxo Group Limited
    Inventors: Dean David Edney, Matthew Peter John
  • Process for the Preparation of a Biphenyl-2-Yl carbamic Acid Ester
    Publication number: 20120046469
    Abstract: A novel process for the preparation of the compound of formula (II): which process comprises reacting a compound of formula (VI): with a compound of formula (IV): in a suitable solvent.
    Type: Application
    Filed: April 14, 2010
    Publication date: February 23, 2012
    Applicant: GLAXO GROUP LIMITED
    Inventors: Dean David Edney, Matthew Peter John
  • NOVEL COMPOUNDS
    Publication number: 20100152148
    Abstract: A compound of formula (I): wherein X represents O or S; R1 represents C1-6 alkyl, C3-8 cycloalkyl, C3-8 cycloalkylmethyl or C3-8 cycloalkenyl any of which optionally may be substituted by one or more methyl groups or halogen atoms or R1 represents aryl, substituted aryl, heteroaryl or substituted heteroaryl; R2 represents hydrogen, methyl, which may be in either the ? or ? configuration, or methylene; R3 and R4 are the same or different and each independently represents hydrogen, halogen or a methyl group; and represents a single or a double bond; or a physiologically acceptable salt or solvate thereof, and pharmaceutical formulations and methods of use thereof.
    Type: Application
    Filed: March 1, 2010
    Publication date: June 17, 2010
    Inventors: Keith Biggadike, Matthew Peter John, Deborah Needham
  • Compounds
    Patent number: 7524970
    Abstract: A compound of formula (I): wherein X represents O or S; R1 represents C1-6 alkyl, C3-8 cycloalkyl, C3-8 cycloalkylmethyl or C3-8 cycloalkenyl any of which optionally may be substituted by one or more methyl groups or halogen atoms or R1 represents aryl, substituted aryl, heteroaryl or substituted heteroaryl; R2 represents hydrogen, methyl, which may be in either the ? or ? configuration, or methylene; R3 and R4 are the same or different and each independently represents hydrogen, halogen or a methyl group; and represents a single or a double bond; or a physiologically acceptable salt or solvate thereof.
    Type: Grant
    Filed: September 28, 2007
    Date of Patent: April 28, 2009
    Assignee: Glaxo Group Limited
    Inventor: Matthew Peter John
  • Specific glucocorticosteroid compound having anti-inflammatory activity
    Patent number: 7288536
    Abstract: A compound of formula (I): wherein X represents O or S; R1 represents C1-6 alkyl, C3-8 cycloalkyl, C3-8 cycloalkylmethyl or C3-8 cycloalkenyl any of which optionally may be substituted by one or more methyl groups or halogen atoms or R1 represents aryl, substituted aryl, heteroaryl or substituted heteroaryl; R2 represents hydrogen, methyl, which may be in either the ? or ? configuration, or methylene; R3 and R4 are the same or different and each independently represents hydrogen, halogen or a methyl group; and represents a single or a double bond; or a physiologically acceptable salt or solvate thereof.
    Type: Grant
    Filed: July 9, 2004
    Date of Patent: October 30, 2007
    Assignee: Glaxo Group Limited
    Inventors: Keith Biggadike, Matthew Peter John, Deborah Needham